Gut vs Hepatology: Which Should You Submit To?

Gut's impact factor is 25.8; Hepatology's is 15.8 (2024 JCR). This is a substantial difference, though smaller than many people assume. Gut ranks at the very top of gastroenterology; Hepatology remains one of the strongest liver journals. Publishing in Gut is a major career achievement; publishing in Hepatology is a strong, respected publication.

However, within the hepatology specialist community, the prestige gap is smaller than the JIF numbers suggest. Hepatologists read and respect Hepatology highly. Within liver disease research, Hepatology is the de facto standard home. For career advancement in hepatology, Hepatology can be as career-defining as Gut, even though Gut's JIF is higher.

Gut publishes research across the entire gastrointestinal tract: esophagus, stomach, small bowel, colon, and pancreas. The journal also covers hepatology (liver disease) as part of its GI scope. This breadth means Gut accepts diverse types of GI research—colorectal cancer, inflammatory bowel disease, pancreatic disease, liver disease, GI motility, and much more. The journal emphasizes high-impact research with implications beyond a single organ system.

Hepatology is exclusively focused on liver disease: viral hepatitis, liver fibrosis and cirrhosis, hepatocellular carcinoma, autoimmune liver disease, metabolic liver disease, and liver transplantation. The journal does not publish GI research outside the liver. This specialization means Hepatology editors are deeply expert in liver pathophysiology and value studies that advance understanding of liver disease mechanisms.

In practice: If your research is about colon cancer, inflammatory bowel disease, or pancreatic disease, Gut is the clear choice—Hepatology doesn't publish it. If your research is liver-specific, both Gut and Hepatology will accept it, but Hepatology is the more specialized home.

Gut editors are highly selective. The journal receives thousands of submissions and desk-rejects the majority within 2-3 weeks. To pass desk review at Gut, your work must be high-impact, novel, and of broad GI significance. Incremental studies, small cohorts, or narrow findings are unlikely to reach peer review. However, papers that pass desk review at Gut are taken very seriously.

Hepatology editors are more permissive. The journal will send well-executed research to peer review even if it's somewhat incremental, as long as it advances understanding of liver disease. The bar for peer review is lower than at Gut, which means more papers get reviewed and more have a path to acceptance.

In practical terms: If you're unsure whether your liver research meets the impact bar, Hepatology is more likely to give you peer review. But if your work is truly high-impact liver research, Gut is the prestige target.

Gut: ~12–15% acceptance rate. Highly competitive, but not as stringent as Nature or Science. Only strong papers make it through.

Hepatology: ~15% acceptance rate. It is still more accessible than Gut, but not by the wide margin some older comparison pages claimed.

The acceptance rate difference reflects the editorial philosophy: Hepatology sends more papers to peer review, and a higher proportion are accepted. If your work is solid but not blockbuster, Hepatology offers better odds.

Gut: ~24 days median to first decision for reviewed papers, with fast editorial triage on submissions that clearly miss the bar.

Hepatology: ~30 days to first decision in current Manusights canonical data.

Both journals move on a multi-week to multi-month timescale once revisions are included, so neither should be treated as a rapid-publication option.

If your research is non-liver GI (colorectal, pancreatic, esophageal, small bowel, etc.): Only Gut will publish it. Hepatology is not an option. Submit to Gut.

If your research focuses on liver disease and you want maximum prestige: Target Gut. It's the higher-impact journal and a Gut paper carries more weight in any field.

If your research focuses on liver disease and you're prioritizing acceptance probability: Try Hepatology first. Better acceptance odds and strong standing within hepatology.

If your research is mechanistic liver science with broad implications: Try Gut first. High-impact mechanistic studies fit Gut's editorial preference.

If your research is solid liver disease research without broad implications: Hepatology is the better fit. Gut will likely desk-reject it as incremental; Hepatology will give it fair peer review.

If you're a hepatologist submitting to Gut with liver research: Expect higher desk-rejection rates. Your work needs to transcend liver-specific significance and have implications for general GI science or human health. If it does, Gut is worth the attempt. If not, Hepatology is your natural home.

If Gut rejects your liver research, Hepatology is an excellent second choice—in fact, it may be the right choice from the start. Hepatology editors read independently and don't penalize papers rejected elsewhere. The feedback from Gut can strengthen your submission for Hepatology. Gut rejection at the desk decision stage suggests your work may be solid but not broad enough for Gut; that's when Hepatology becomes the logical target.

Conversely, if Gut accepts your liver research, you're in an elite group. Gut's lower acceptance rate means Gut acceptance is a significant career achievement.

Gut is the prestige journal—broader scope, higher impact, more competitive. Hepatology is the specialist journal—liver-focused, more accessible, deeply respected within hepatology. For general GI research, Gut is the only choice. For liver research, Gut is the prestige target, but Hepatology is the specialist home. Many successful hepatologists publish their career's most important work in Hepatology, not Gut. Choose based on scope, impact ambitions, and acceptance odds.